News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,674 Results
Type
Article (43739)
Company Profile (274)
Press Release (674661)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (208406)
Career Advice (2101)
Deals (35988)
Drug Delivery (101)
Drug Development (82451)
Employer Resources (174)
FDA (16787)
Job Trends (15170)
News (352552)
Policy (33519)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2719)
Accelerated approval (5)
Adcomms (21)
Allergies (84)
Alliances (51121)
ALS (93)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (124)
Approvals (16783)
Artificial intelligence (256)
Autoimmune disease (25)
Automation (15)
Bankruptcy (362)
Best Places to Work (11886)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (197)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (276)
Cancer (2182)
Cardiovascular disease (173)
Career advice (1750)
Career pathing (30)
CAR-T (151)
Cell therapy (419)
Cervical cancer (20)
Clinical research (66863)
Collaboration (836)
Compensation (520)
Complete response letters (21)
COVID-19 (2664)
CRISPR (40)
C-suite (237)
Cystic fibrosis (102)
Data (2105)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (266)
Diagnostics (6513)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (91)
Earnings (87312)
Editorial (35)
Employer branding (21)
Employer resources (148)
Events (114713)
Executive appointments (716)
FDA (18007)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (108)
Generative AI (22)
Gene therapy (299)
GLP-1 (717)
Government (4559)
Grass and pollen (4)
Guidances (51)
Healthcare (19459)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (117)
Indications (28)
Infectious disease (2805)
Inflammatory bowel disease (134)
Inflation Reduction Act (9)
Influenza (50)
Intellectual property (92)
Interviews (323)
IPO (16663)
IRA (42)
Job creations (3698)
Job search strategy (1488)
Kidney cancer (11)
Labor market (36)
Layoffs (466)
Leadership (18)
Legal (8096)
Liver cancer (74)
Lung cancer (315)
Lymphoma (149)
Machine learning (5)
Management (59)
Manufacturing (300)
MASH (63)
Medical device (13928)
Medtech (13933)
Mergers & acquisitions (19849)
Metabolic disorders (677)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1943)
NextGen: Class of 2025 (6782)
Non-profit (4611)
Northern California (2592)
Now hiring (38)
Obesity (364)
Opinion (213)
Ovarian cancer (74)
Pain (86)
Pancreatic cancer (81)
Parkinson's disease (150)
Partnered (21)
Patents (229)
Patient recruitment (105)
Peanut (48)
People (58405)
Pharmaceutical (66)
Pharmacy benefit managers (20)
Phase I (20887)
Phase II (29444)
Phase III (21904)
Pipeline (1140)
Policy (136)
Postmarket research (2606)
Preclinical (8909)
Press Release (69)
Prostate cancer (100)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (383)
Real estate (6053)
Recruiting (66)
Regulatory (22927)
Reports (46)
Research institute (2448)
Resumes & cover letters (366)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (68)
Series A (132)
Series B (86)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2230)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3691)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (28)
The Weekly (29)
United States (22619)
Vaccines (700)
Venture capitalists (40)
Weight loss (237)
Women's health (34)
Worklife (15)
Date
Today (182)
Last 7 days (547)
Last 30 days (2475)
Last 365 days (33407)
2025 (9795)
2024 (35800)
2023 (40808)
2022 (51978)
2021 (56630)
2020 (55199)
2019 (47983)
2018 (36149)
2017 (33123)
2016 (32605)
2015 (38725)
2014 (32437)
2013 (27612)
2012 (29800)
2011 (30436)
2010 (28427)
Location
Africa (762)
Alabama (52)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (39439)
Australia (6449)
California (5932)
Canada (1969)
China (505)
Colorado (263)
Connecticut (279)
Delaware (138)
Europe (85841)
Florida (876)
Georgia (209)
Idaho (61)
Illinois (529)
India (26)
Indiana (305)
Iowa (10)
Japan (157)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (885)
Massachusetts (4460)
Michigan (216)
Minnesota (394)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (60)
New Hampshire (65)
New Jersey (1688)
New Mexico (29)
New York (1703)
North Carolina (965)
North Dakota (7)
Northern California (2592)
Ohio (202)
Oklahoma (14)
Oregon (35)
Pennsylvania (1329)
Puerto Rico (11)
Rhode Island (32)
South America (1147)
South Carolina (21)
South Dakota (1)
Southern California (2230)
Tennessee (101)
Texas (880)
Utah (175)
Virginia (143)
Washington D.C. (61)
Washington State (555)
West Virginia (3)
Wisconsin (51)
718,674 Results for "sparta systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
September 17, 2024
·
3 min read
Bio NC
Sparta Biomedical to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
Sparta Biomedical, a privately held medical device company specializing in partial knee resurfacing, is set to present at the highly anticipated Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024.
January 17, 2024
·
1 min read
Bio NC
Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round.
September 12, 2023
·
2 min read
Press Releases
CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients
April 23, 2025
·
4 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Drug Development
Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation
Apollomics Inc. today announced the addition of two new cohorts in its ongoing global multi-cohort Phase 2 SPARTA study (NCT03175224), which is evaluating vebreltinib (APL-101) in patients with non-small cell lung cancer (NSCLC) and other solid tumors.
October 31, 2023
·
6 min read
Drug Development
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
August 13, 2024
·
7 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tivic Health Systems, Inc. Announces Reverse Stock Split
March 5, 2025
·
6 min read
Bio NC
Sparta Biomedical’s Breakthrough Device, Ormi, to be Featured at the 17th ICRS World Congress on September 10, 2023
Sparta Biomedical, a privately held medical device company specializing in partial knee resurfacing, is excited to announce Dr. Adam Yanke’s presentation at the 2023 ICRS World Congress in Barcelona, Spain.
September 8, 2023
·
1 min read
1 of 71,868
Next
